1-1 of 1
Vivek Anand
Close
Sort by
Journal Articles

Activin-like Kinase 2 (ALK2/ACVR1) Is a Resistance Factor and Therapeutic Vulnerability to FLT3 Inhibition in Acute Myeloid Leukemia

Anudishi Tyagi, Stanley Ly, Bin Yuan, Fouad El-Dana, Vivek Anand, Appalaraju Jaggupilli, Gautam Borthakur, Jason M Foulks, Steven L. Warner, Venkata Lokesh Battula
Journal: Blood
Blood (2022) 140 (Supplement 1): 3052–3053.
https://doi.org/10.1182/blood-2022-167580
Published: 2022